Annual Review of Medicine

Papers
(The TQCC of Annual Review of Medicine is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Clonal Hematopoiesis and Its Impact on Human Health410
Carbon Monoxide Poisoning: From Microbes to Therapeutics334
Interventional Pulmonology: Extending the Breadth of Thoracic Care186
Emerging Therapies in Hypothyroidism180
Normal Gut Microbiomes in Diverse Populations: Clinical Implications167
The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies131
Contemporary Management of Acute Ischemic Stroke121
Hypertension Management in Pregnancy117
Organoid Models for Infectious Disease101
COVID-19: Inflammatory Profile93
Diverse Approaches to Gene Therapy of Sickle Cell Disease92
Clinical Phenotypes of Cystic Fibrosis Carriers91
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines76
Adeno-Associated Virus Gene Therapy for Hemophilia75
Polypharmacy and Deprescribing in Older Adults73
Wearable Devices: Implications for Precision Medicine and the Future of Health Care73
COVID-19 Vaccines: Adenoviral Vectors70
What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?68
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic Complication62
Update in Adult Transgender Medicine58
58
Healthy and Unhealthy Aging and the Human Microbiome54
RASopathies in Cardiac Disease53
Circulating Tumor DNA: A Pan-Cancer Biomarker in Solid Tumors with Prognostic and Predictive Value52
Update on Hepatorenal Syndrome: From Pathophysiology to Treatment43
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer43
The Evolving Practice of Hospital at Home in the United States39
Treatments for COVID-1938
New Biological Therapies for Multiple Myeloma38
The Hospitalist Movement 25 Years Later36
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells36
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment36
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics35
Update on the Porphyrias33
SGLT2 Inhibitors: The Sweet Success for Kidneys33
Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts31
All the Tau We Cannot See31
0.023377895355225